GENE ONLINE|News &
Opinion
Blog

R&D
Novartis Announces Mayzent Data that Shows Extended Benefit in Secondary Progressive MS
2020-04-21
Cancer Drug Resistance: Implications in Cancer Therapy
2020-04-20
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
The Search for Disease-Modifying Osteoarthritis Drugs (DMOADs): The Holy Grail of Osteoarthritis Research
2020-04-12
Regeneron & Sanofi’s Phase 3 Dupixent Data on Children Under Regulatory Review
2020-04-10
R&D
Gilead, Second Genome Partner to Explore Microbial Biomarkers
2020-04-08
Samsung Biologics Inks CDO Contract with PharmAbcine to Develop Novel Drug
2020-04-08
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
Mochida Pharma, Gene Techno Science Collaborate to Develop Regenerative Medicine for Rare Disease
2020-03-28
R&D
Weekly Cover: Eisai to Launch “NouKNOWTM” in Japan for Regular Self-assessment of Brain Health
2020-03-26
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Roche’s Elecsys GALAD Score that Predicts HCC Occurrence, Bags Breakthrough Designation
2020-03-06
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
1 29 30 31 32 33 35
LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top